An oral phosphodiesterase 4 inhibitor may offer significant improvement in signs and symptoms of psoriatic arthritis, according to preliminary trial data.
Dermatology Times September 2024 Print Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Promising Long-term Results for ESK-001 in Psoriasis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Vitiligo News: The Year Thus Far
Dermatology Conferences and Meetings Calendar 2024: October